Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Erectile Dysfunction: later-stage trial registry
14 of 34 indexed Erectile Dysfunction trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #451 of 28,707 conditions by registered trial count.
34 US clinical trials · 14 currently recruiting · #451 of 28,707 conditions by registered trial count
Erectile Dysfunction: 34 US clinical trials tracked, 14 recruiting.
Erectile Dysfunction is the subject of 34 registered US clinical trials on ClinicalTrials.gov, 14 of them currently open to new participants. 10 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Mayo Clinic, running 3 of these trials.
Enrollment posture brief
Registry condition erectile-dysfunction
OPEN 14 | RECR 41% | LATE 10 | EARLY 4 | RANK #451 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Fragile X Syndrome (41% recruiting · 17 trials)
Erectile Dysfunction lists 14 open slots (41% of 34 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Erectile Dysfunction on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Erectile Dysfunction recruits in line with its size-band peers.
14 of 34 indexed trials (41.2%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Erectile Dysfunction trials is spread across many organizations.
Mayo Clinic accounts for 3 of 34 trials (8.8%). 25 distinct sponsors appear on at least one study for this condition label.
-
Typical Erectile Dysfunction enrolment sits around 74 participants.
Median target enrolment is 74 among the 34 trials that report a genuine target (sentinel values excluded). 19 of those (55.9%) plan for fewer than 100 participants.
-
Erectile Dysfunction research is mostly interventional.
32 interventional and 2 observational studies make up this index (94.1% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
34 total, page 1 of 1
Actual Use Trial of Tadalafil 5 mg
Sanofi
NCT06805513
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
Memorial Sloan Kettering Cancer Center
NCT02706561
SAFE Nerve Sparing Guided by Micro-ultrasound (MUS)
Icahn School of Medicine at Mount Sinai
NCT06945315
Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain
The Cleveland Clinic
NCT05868668
EndoPAT Device for Endothelial Dysfunction in ED
University of California, Irvine
NCT06720597
Safety and Efficacy of the VERTICA® RF Device for the Treatment of ED
OHH-MED Medical
NCT06167733
Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease
Mayo Clinic
NCT06065436
Penile Lengthening Pre-Penile Prosthesis Implantation
University of Pittsburgh
NCT07053826
The Impact of Dietary Pattern on Erectile Function
Montefiore Medical Center
NCT04349059
The Impact of a Plant-based Meat Meal Versus an Animal Meat Meal on Erectile Function in Healthy Men.
Montefiore Medical Center
NCT06273592
Prostate Stimulation for Sexual Dysfunction
Stanford University
NCT05468931
The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 mg Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fed Versus 100 mg of Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fasted Conditions in Healthy Adult Male Subjects
Aspargo Labs
NCT06872866
Double-S: a Wearable Device for Erectile Dysfunction
Stanford University
NCT05451563
External Device for Erectile Dysfunction (3D-Erect)
Stanford University
NCT04624126
Collaborative Urological Prosthetics Investigation Directive Research Group
University of Chicago
NCT05100654
Low Intensity Shockwave Therapy for Erectile Dysfunction
University of Virginia
NCT04434352
Irrisept vs Traditional Antibiotic Irrigation for Virgin Penile Prosthesis Placement
Rush University Medical Center
NCT06489431
Penile Injection Anxiety
Memorial Sloan Kettering Cancer Center
NCT00582231
A Study to Investigate the Time to Onset of Action of 10 mg and 20 mg of Vardenafil Compared to Placebo in Males With Erectile Dysfunction
Bayer
NCT00665496
Treatment of Erectile Dysfunction I
Warner Chilcott
NCT01037244
Treatment of Erectile Dysfunction II
Warner Chilcott
NCT01037218
Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer
Memorial Sloan Kettering Cancer Center
NCT00142506
Study to Investigate the Efficacy and Safety of Vardenafil Flexible Dose Versus Placebo in Males With Erectile Dysfunction
Bayer
NCT00657033
A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy
Astellas Pharma
NCT00106392
An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract Symptoms
Chesapeake Urology Research Associates
NCT00893113
Drug Interaction Study of Avanafil and Enalapril or Amlodipine
VIVUS
NCT01117038
Evaluation of the Coloplast Titan® IPP for Maintaining Penile Length While Treating Erectile Dysfunction (ED)
Coloplast A/S
NCT00731666
Autologous Bone Marrow Concentrate in Treatment of Erectile Dysfunction.
Creative Medical Health
NCT03699943
The Incidence and Treatment of Insulin Resistance Among Men With Erectile Dysfunction
Milton S. Hershey Medical Center
NCT00284960
Use of an External Erectile Device in Transgender Man Following Phalloplasty
Boston Children's Hospital
NCT03823014
Transpelvic Magnetic Stimulation to Improve Urogenital Function
VA Office of Research and Development
NCT04488068
Uroxatral in Men With Benign Prostate Hypertrophy (BPH) and Erectile Dysfunction (ED)
University Hospitals Cleveland Medical Center
NCT00256399
Low Intensity Shock Wave Therapy in the Management of Erectile Dysfunction
Mayo Clinic
NCT04136288
PRP for the Treatment of Erectile Dysfunction (ED)
Mayo Clinic
NCT04350125
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 3 | 9 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Erectile Dysfunction records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Erectile Dysfunction trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Erectile Dysfunction page
34 registered trials, 14 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 14 Erectile Dysfunction trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Mayo Clinic sponsors the most Erectile Dysfunction trials on record, review their full trial history before evaluating a specific study. See Mayo Clinic's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Erectile Dysfunction condition card totals 34 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.